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ABSTRACT 
Due to the capability of self-renewal and differentiation, embryonic stem cells (ESCs) are 
an invaluable tool for research in regenerative medicine. However, the main problem that 
hampers application of ESCs to practical stem cell therapies is that ESCs can grow as 
tumors when transplanted. To date, only one oncogene Eras is known to be responsible 
for tumorigenic growth of ESCs. Thus, the tumorigenic property of ESCs is poorly 
investigated.  
      By global gene expression profiling of mouse ESCs, surprisingly I found that the 
oncogene Gli2, a downstream target of the growth factor Sonic hedgehog (Shh), was 
expressed in undifferentiated mouse ESCs, which was further validated by semi-
quantitative RT-PCR and immunofluorescent microscopy. It is well-known that the Gli2 
protein is activated by Shh. However, interestingly, the Gli2 transcripts were expressed 
abundantly in mouse ESCs without endogenous Shh expression detected. 
      To test if expression of Gli2 in mouse ESCs is based on an autonomous mechanism 
or due to a signal(s) from the extracellular environment, mouse ESCs were cultured in 
either standard or chemically-defined serum-free conditions (CDSF) for 3 passages. 
Growth rates and expression levels of the transcription factor Oct3/4 (Pou5f1), a master 
regulator of pluripotency in mouse ESCs, were monitored. The mouse ESCs maintained 
in these conditions showed similar levels of Oct3/4 expression, but no endogenous Shh 
expression. However, intriguingly, the mouse ESCs maintained in CDSF conditions 
downregulated Eras and Gli2 expression, and exhibited a slower growth rate.  
      Next, the mouse ESCs cultured in these conditions were injected subcutaneously into 
NOD-SCID mice to test their tumorigenicity. The mouse ESCs maintained in standard 
 
 
iii 
conditions generated a well-developed tumor in 4 weeks, whereas the mouse ESCs 
cultured in CDSF conditions failed to form a tumor up to 6 months. When CDSF culture 
was supplemented with the serum as a positive control, these mouse ESCs upregulated 
Gli2 expression, proliferated at the similar rate to the ones maintained in the normal 
conditions, and regained tumorigenicity.  
      Remarkably, when mouse ESCs were cultured under CDSF conditions supplemented 
with a pharmacological inhibitor of Gsk3β, they efficiently proliferated and developed 
into teratomas without upregulation of Eras and c-Myc, but had upregulated Gli2 
expression. These findings indicate that Gli2 expression is tightly correlated with the 
incidence of tumor-like growth of mouse ESCs.  
      Taken together, these results indicate that Gli2 expression is associated with the 
tumorigenic property of mouse ESCs, which can serve as a novel marker. Further, we 
suggest that tumorigenicity in mouse ESCs can be manipulated without comprising the 
pluripotency of mouse ESCs by maintaining mouse ESCs in CDSF conditions. The 
tumorigenic growth of mouse ESCs is reversed by pharmacological inhibition of Gsk3β, 
which suggests that Gsk3β governs the tumor-like growth of mouse ESCs by means of a 
mechanism different from the one to support the pluripotency of ESCs. 
 
 
 
 
 
 
 
 
iv 
ACKNOWLEDGEMENTS 
 
It is my pleasure to thank all the professors, colleagues and friends who made this thesis 
possible. I owe my deepest gratitude to my Master’s thesis supervisor, Dr. Tetsuya S. 
Tanaka, for his guidance, encouragement and inspiration. I appreciate technical support 
from all the Lab members, Paig Tsai, Chang Liu, Dana Leben and Tamaki Tamaki. I also 
want to express my gratitude to my close friend Jiajia Bi in Dr. Romana A. Nowak’s Lab 
for his insights in histological experiments and microcopy.  
      It is an honor for me to have Dr. Janice M. Bahr as my committee chair. I am grateful 
for the experimental facility she shared with us and her support and care for me. I would 
like to thank Dr. Fei Wang and his Lab for providing human cell lines and instruction on 
human ESCs culture. I am indebted to Dr. Suzanne E. Berry-Miller for her inspirational 
discussion and her stem cell journal club, where I can grow up in science with a group of 
friends.  
      My appreciation also goes to Department of Animal Sciences and Institute for 
Genomic Biology for all the resources during my thesis research. I thank the Travel 
Award from Animal Sciences Department and AYRE International Research and 
Learning Fellowships from College of Agricultural, Consumer and Environmental 
Sciences. I also thank the funding from the USDA Hatch Project (ILLU-538-323), 
University of Illinois and the Illinois Regenerative Medicine Institute. 
      My gratitude also goes to my dear husband and family who give me unconditional 
love and support. I also heartily thank all my church friends for all the prayers and care. 
Praise the Lord!   
v 
 
TABLE OF CONTENTS 
 
 
CHAPTER 1: Literature Review …………………………………………………………1 
 
CHAPTER 2: Short-term serum-free culture reveals that inhibition of Gsk3β induces the 
                        tumor-like growth of mouse embryonic stem cells………………………15 
 
CHAPTER 3: Gli2 expression is associated with the tumorigenicity of mouse embryonic 
                        stem cells…………………………………………………………………44 
 
CHAPTER 4: Conclusion ……………………………………………………………….67 
 
REFERENCES ………………………………………………………………………….70 
1 
 
CHAPTER 1 
Literature Review 
 
Abstract 
Embryonic stem cells (ESCs) are derived from preimplantation embryos and are capable 
of both long-term proliferation (self-renewal) and differentiation into cell types of all 
three germ layers (pluripotency). The self-renewal and pluripotency of ESCs are 
sustained by certain essential transcription factors. Intriguingly, the viral transduction of 
these transcription factors into differentiated adult somatic cells results in reprogramming 
of the developmental process that the somatic cells have undergone. Consequently, 
pluripotent cells similar to ESCs, termed induced pluripotent stem cells, can be 
artificially established from specialized cells. These two types of pluripotent stem cells 
(PSCs) have held the promise of providing customized tissue replacements as well as 
platforms for drug screening since they were first derived from human tissues and 
embryos. However, the heterogeneous nature of PSC cultures, which may reflect the 
plasticity of early embryonic cells, hampers the establishment of a definitive and 
reproducible culture microenvironment. In addition, the induction of PSC differentiation 
is dependent on random events and generates heterogeneous populations of specialized 
cells. Furthermore, PSCs, by definition, are able to generate benign tumors called 
teratomas, which consist of cell types of three germ layers. To prevent the growth of 
teratomas in therapeutic transplanted tissue replacements, it is necessary to establish 
techniques for efficiently manipulating cell fate decisions in PSCs and to understand the 
mechanism responsible for tumorigenesis in the stem cells. To our surprise, the 
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mechanism of teratoma formation from PSCs has received little attention to date. Thus, to 
understand better self-renewal, pluripotency and tumorigenesis in PSCs, this chapter will 
address the following three simple but overlooked questions:   
 
1. Does every pluripotent stem cell possess identical self-renewal capability? 
2. Are current standard culture conditions optimal for maintaining pluripotent stem 
cells? 
3. Is the mechanism of their tumor-like growth known? 
 
Pluripotent Stem Cells Generate Heterogeneous Populations 
 
Pluripotent Stem Cells  
Pluripotent stem cells (PSCs) are an excellent model to study mechanisms of cellular 
pluripotency and differentiation in vitro because of their capacity for self-renewal and 
their capability to become most kinds of specialized cells, including germ cells. The 
identification and characterization of a mouse strain that naturally develops testicular 
teratoma (Stevens, 1973; Stevens and Little, 1954) contributed to demonstrating that 
teratomas originate from PSCs (Solter, 2006). A benign teratoma, normally found in 1 
out of 40,000 live births (Barksdale and Obokhare, 2009), is a “monstrous“ tumor 
consisting of specialized cells derived from all three germ layers ectoderm, mesoderm 
and endoderm. The first PSCs, embryonic carcinoma cells (ECCs), were derived from 
malignant teratocarcinomas, which were experimentally generated by transplantation of 
peri-implantation embryos into the testes of host animals (Stevens, 1970). ECCs are 
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transplantable, in that they will develop into teratocarcinomas when transplanted. 
Because ECCs are pluripotent, the original study established an in vitro system to study 
the cell fate decision mechanism. Furthermore, this study indicated that there could be 
another kind of PSCs in early embryos that could be directly established by in vitro 
culture, but not by transplantation, of early embryos. During mouse preimplantation 
development, the first cell differentiation event gives rise to the pluripotent inner cell 
mass (ICM) and the lineage-committed trophectoderm. When cultured on embryonic 
fibroblasts, the ICM gives rise to pluripotent stem cells. Mouse embryonic stem cells 
(ESCs) were successfully derived in 1981 (Evans and Kaufman, 1981) and have been the 
primary model used to investigate mechanisms of cell fate decision. Similar PSCs were 
later established from primordial germ cells, namely embryonic germ cells (Matsui et al., 
1992). These studies on mouse embryos paved the way for the derivation of embryonic 
stem and germ cells from human embryos (Shamblott et al., 1998; Thomson et al., 1998). 
The derivation of PSCs from human embryos shed light on regenerative medicine and 
helped to expand this field of research (Tanaka, 2010). ESCs have been derived from a 
variety of species (Tanaka, 2010). Studies on self-renewal and pluripotency using ESCs 
further enabled the establishment of other kinds of PSCs, including early primitive 
ectoderm-like stem cells (EPLCs; Rathjen et al., 1999) and epiblast-derived stem cells 
(EpiSCs; Brons et al., 2007; Tesar et al., 2007). Because EpiSCs are derived from, and 
EPLCs are thought to be equivalent to, cells of post-implantation embryos, their 
capabilities to generate differentiated cells are more restricted than those of ESCs 
(Hiratani et al., 2010). That is, embryonic development proceeds by restricting a cell’s 
ability to generate specialized cells. Therefore, a method to erase such acquired 
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restrictions in specialized cells was sought to restore differentiated cells to the pluripotent 
state. This was first achieved by transferring somatic cell nuclei into enucleated oocytes 
(Briggs and King, 1952; Campbell et al., 1996; Gurdon and Melton, 2008; Rideout et al., 
2002; Wakayama et al., 1998). Intriguingly, recent studies have shown that delivering 
extra copies of four transcription factors that orchestrate self-renewal and pluripotency 
into differentiated cells results in the reprogramming of the specialized cells into PSCs, 
called induced pluripotent stem cells (iPSCs; Takahashi and Yamanaka, 2006). Since the 
successful derivation of iPSCs from human cells (Thomson et al., 1998; Takahashi et al., 
2007; Yu et al., 2007), iPSCs have been considered to hold great potential for developing 
customized replacement tissues and for providing platforms for drug screening. However, 
cells differentiated from PSCs in vitro that have been transplanted into animal disease 
models (for example, Brederlau et al., 2006; Jomura et al., 2007; Kerr et al., 2003) tend to 
develop into teratomas due to residual populations of undifferentiated PSCs. Thus, a 
better understanding of extrinsic and intrinsic factors involved in cell fate decisions and 
tumorigenesis in PSCs is necessary to significantly improve iPSC-based stem cell therapy.  
 
Extrinsic Factors for Maintenance of Self-renewal 
The derivation of ESC lines from human and mouse embryos could not have been 
accomplished without feeder layers of embryonic fibroblasts. Although cultured ECCs do 
not require a layer of feeder cells for growth, both embryonic germ cell and iPSC cultures 
do. Interestingly, conditioned medium (CM) from embryonic fibroblasts was sufficient to 
support the culture of undifferentiated mouse ESCs in the absence of feeder layers (Smith 
and Hooper, 1983). Analysis of components in CM led to the identification of the 
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leukemia inhibitory factor (LIF) as a differentiation inhibitor (Smith et al., 1988; 
Williams et al., 1988). These studies laid the foundation for investigating the dependence 
of self-renewal and pluripotency of ESCs on other extrinsic factors. In addition to LIF, 
the maintenance of mouse ESC culture requires bone morphogenetic protein 4 (Bmp4; 
Ying et al., 2003), vitamin A (retinol and retinoic acid; Chen and Khillan, 2008; Chen 
and Khillan, 2010; Wang et al., 2008), threonine (Wang et al., 2009) and a decreased 
oxidation state (Yanes et al., 2010). The existence of another extrinsic factor independent 
from the LIF/Stat3 signal, namely ES cell renewal factor, has also been postulated (Dani 
et al., 1998). The supplementation of basal culture media with animal sera, such as fetal 
bovine serum (FBS), provides all of these extrinsic factors except LIF. Although human 
ESCs are similar to mouse ESCs with respect to their self-renewal and pluripotency, the 
extrinsic factors necessary for mouse ESC culture failed to support the culture of human 
ESCs. For example, the combination of LIF and serum could not support long-term self-
renewal of human ESC lines (Bongso et al., 1994). Furthermore, Bmp4 promoted 
differentiation of human ESCs into trophoblasts (Xu et al., 2002), whereas long-term 
proliferation of these cells was maintained in the presence of Noggin, an antagonist of 
Bmp4 (Wang et al., 2005; Xu et al., 2005b). Instead, the maintenance of human ESC 
self-renewal and pluripotency mainly relies on basic fibroblast growth factor (bFGF; Xu 
et al., 2005a). In addition, members of the transforming growth factor β (TGFβ) 
superfamily, especially TGFβ, activin and Nodal, are essential for maintaining the 
pluripotency of human ESCs in combination with bFGF (Beattie et al., 2005; James et al., 
2005; Vallier et al., 2005). Mouse and human iPSCs exhibit dependency on extrinsic 
factors similar to mouse and human ESCs, respectively. Mouse and rat EpiSCs are 
6 
 
dependent on activin and bFGF to sustain self-renewal and pluripotency, and thus human 
ESCs are more similar to these EpiSCs. These discrepancies are attributed to differences 
in development between mouse and human embryos, even though mouse and human 
ESCs have been derived from embryos at similar developmental stages. Very 
interestingly, it has been suggested that the reprogramming process makes human iPSCs 
more similar to mouse ESCs (Hanna et al., 2010). ECCs do not exhibit dependency on 
extrinsic factors, whereas the maintenance of embryonic germ cells requires LIF, bFGF 
and the c-Kit ligand, Steel factor (Matsui et al., 1991; Matsui et al., 1992). Thus, signals 
from these extrinsic factors may converge in maintaining the activity of a common set of 
intrinsic genetic factors that define cellular “stemness“. 
 
Intrinsic Factors to Maintain Self-renewal 
Maintenance of the self-renewal and pluripotency of mouse ESCs relies on the activity of 
the downstream target of the LIF signal, the Stat3 transcription factor (Matsuda et al., 
1999; Niwa et al., 1998). However, key players further downstream of Stat3 are essential 
for these processes because the LIF/Stat3 signaling pathway is not required for the 
maintenance of pluripotent cells in developing embryos or for the self-renewal and 
pluripotency of human ESCs (Dani et al., 1998; Tanaka, 2009). This pathway may 
interact with the transcription factors Oct3/4/ Pou5f1 (Nichols et al., 1998; Niwa et al., 
2000), Sox2 (Avilion et al., 2003; Masui et al., 2007), Nanog (Chambers et al., 2003; 
Mitsui et al., 2003), Klf4 (Li et al., 2005) and c-Myc (Cartwright et al., 2005). In a steady 
state, a balance of the relative expression levels of these genes is essential for fate 
decisions of mouse ESCs (Fujikura et al., 2002; Niwa et al., 2005). The genetic network 
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of these transcription factors and the expression of their downstream target genes have 
been elucidated by genomic approaches (Boyer et al., 2005; Ivanova et al., 2002; Loh et 
al., 2006; Matoba et al., 2006; Ramalho-Santos et al., 2002; Tanaka et al., 2002; Walker 
et al., 2007). These genomic approaches revealed that cellular pluripotency is 
characterized by the expression of a unique set of genes that suppress transcripts 
associated with cellular differentiation. Recently, the self-renewal of mouse ESCs was 
shown to be maintained by simple pharmacological inhibition of Erk, which is 
downstream of FGF receptors, and the inhibition of Gsk3β activity (Ying et al., 2008). 
Because mouse ESCs express Fgf4 (Wilder et al., 1997), these studies indicate that ESCs 
maintain self-renewal by competing against their own differentiation-inducing signals. 
Mouse and human ESCs express Wnt (Lako et al., 2001; Nordin et al., 2008; Okoye et 
al., 2008), which is the biological inhibitor of Gsk3β, and the pharmacological inhibition 
of Gsk3β alone promotes self-renewal of both mouse and human ESCs (Sato et al., 2004) 
as well as derivation of ESC from the ICM (Umehara et al., 2007). However, exogenous 
Wnt promotes the differentiation of mouse (Lindsley et al., 2006) and human (Wang and 
Nakayama, 2009) ESCs. Thus, the role of Wnt in the self-renewal of ESCs requires 
further investigation. Finally, a comparison of global gene expression profiles of mouse 
ESCs of different genetic backgrounds, teratocarcinoma cells (ECCs) and embryonic 
germ cells showed that the expression of Rex1 was higher in cells with greater 
pluripotency (Sharova et al., 2007). The zinc-finger protein Rex1/ Zfp42 was originally 
identified as one of the genes whose expression was downregulated when the 
teratocarcinoma cell line F9 was induced to differentiate by retinoic acid (Hosler et al., 
1989). However, the targeted knockout of Rex1 revealed that it is not required for the 
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maintenance of self-renewal (Masui et al., 2008). There are several genes expressed 
specifically in pluripotent embryonic cells at significant levels, which do not play any 
essential role in pluripotency (e.g., Esg1/ Dppa5; Amano et al., 2006; Tanaka et al., 2006; 
Western et al., 2005). 
 
Transcriptional Heterogeneity in Pluripotent Stem Cells 
One of the challenges in understanding the mechanism of self-renewal and pluripotency 
of PSCs is that cultured ESCs consist of cell populations that show fluctuating expression 
of genes. That is, a bulk preparation of ESCs may only show an averaged state of ESCs 
and thus obscure the presence of distinct ESC populations. Therefore, a better 
understanding of gene expression at the cellular level is critical. In fact, several groups 
have performed expression microarray analyses at the single-cell level and have revealed 
populations of cells that differ in their transcript profiles (Chiang and Melton, 2003; 
Crino et al., 1998; Kurimoto et al., 2006; Ramos et al., 2006; Tang et al., 2010). Several 
studies, including ours, have found that well-maintained mouse ESC cultures consist of a 
small percentage of cells that show fluctuating expression levels of genes such as Dppa3 
(Stella/Pgc7; Hayashi et al., 2008; Payer et al., 2006), Nanog (Chambers et al., 2007; 
Singh et al., 2007), Pecam1 (Furusawa et al., 2004; Furusawa et al., 2006), Rex1 
(Toyooka et al., 2008) and Zscan4 (Falco et al., 2007; Zalzman et al., 2010), or genes 
associated with cell differentiation, such as Brachyury/T (Suzuki et al., 2006a; Suzuki et 
al., 2006b), Rhox6/9 (Carter et al., 2008), Tcf15 and Twist2 (Tanaka et al., 2008). These 
genes are either downregulated (Nanog and Rex1) or expressed (the rest) in about one-
tenth of cells in culture as a steady state (Tanaka, 2009). Mouse ESCs showing 
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fluctuating expression of Nanog, Rex1, T, Dppa3 and Zscan4 have been extensively 
characterized. When mouse ESCs were sorted according to expression levels of one of 
these genes and cultured separately, the resulting ESC populations eventually showed 
similar fluctuating expression of the gene. For example, when sorted Zscan4-positive and 
-negative subpopulations were replated and cultured separately, both subpopulations 
regained Zscan4-negative and -positive cells, respectively (Zalzman et al., 2010). Each 
subpopulation possessed a unique differentiation potential. Thus, the heterogeneous 
nature of PSCs may reflect the plasticity of early embryonic cells (Hayashi et al., 2008; 
Zalzman et al., 2010). The underlying mechanism responsible for inducing the 
transcriptional heterogeneity in ESCs remains largely unknown. However, as will be 
discussed in the following sections, ESCs in culture may have received some signals 
from the microenvironment, such as the stiffness of culture dishes and serum components, 
which initiate the heterogeneous transcription of these genes. 
 
Impact of Culture Conditions on the Self-renewal of Pluripotent Stem Cells 
 
Stiffness of a Culture Dish  
When LIF is supplied in the culture medium, mouse ESCs can be maintained on gelatin-
coated plates without a layer of embryonic fibroblasts as feeders (Robertson, 1987). 
Similarly, human ESCs can be maintained on plates coated with Matrigel (a basement 
membrane preparation extracted from a murine Englebreth-Holm-Swarm sarcoma) 
independent of a feeder layer in a chemically defined culture medium. Interestingly, other 
extracellular matrix proteins elicit different responses from ESCs. For example, collagen 
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IA promotes the self-renewal of mouse ESCs (Furue et al., 2005), and fibronectin and 
laminin help decrease their differentiation potential (Hayashi et al., 2007; Hayashi et al., 
2010). Collagen IV is an inducer of mesoderm lineages for both mouse and human ESCs 
(Schenke-Layland et al., 2007). Intriguingly, the analysis of Matrigel components has led 
to the discovery of synthetic polymers that can support the long-term self-renewal of 
human ESCs (Melkoumian et al., 2010; Rodin et al., 2010; Villa-Diaz et al., 2010). 
Recently, it has become evident that cell fate decisions in stem cells are regulated by 
matrix elasticity or substrate stiffness (Discher et al., 2009). For example, synthetic soft 
substrates (Elasticity, E = ~1 kPa) that mimic the elasticity of the brain induced the 
differentiation of neurons from mesenchymal stem cells, whereas stiffer substrates (E = 
~40 kPa) that mimic the elasticity of collagenous bone induced the differentiation of 
osteoblasts (Engler et al., 2006). In contrast, mouse ESCs are intrinsically soft and 
respond optimally to physical forces when cultured on substrates that match their intrinsic 
softness, which is 0.6 kPa (about 7000-fold softer than plastic culture dishes; 
(Chowdhury et al., 2010). In culture conditions, mouse ESCs are grown on much harder 
substrates than any tissue in vivo. Remarkably, when mouse ESCs are plated on the soft 
substrate (0.6 kPa), they grew as uniformly round colonies without any noticeable 
differentiating colonies  and are able to maintain the expression of markers for 
pluripotent cells, such as Oct3/4 , alkaline phosphatase and Nanog (Chowdhury, Li, 
Wang and Tanaka submitted to PLoS ONE). Therefore, substrate stiffness is a critical 
extrinsic factor to sustain the self-renewal of mouse ESCs. 
 
Culture Conditions with Animal Serum 
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Animal serum provides nutrients, hormones, growth factors, steroids and matrix proteins 
to cultured cells. It also contains remnants of plasma components used for the activation 
and processing of blood clots as well as other substances that do not normally pass 
through the endothelial barrier (Hewlett, 1991; Holliday, 1999; Sato et al., 2010). Despite 
the fact that animal serum is similar but not identical to the interstitial fluid (i.e., lymph) 
that surrounds cells in vivo, animal serum is preferred for cell culture because it 
significantly improves the growth of cells. However, animal serum is also known to 
negatively impact cells in culture (Sato, 1975). For example, complement in serum may 
inhibit cell growth; these components may be inactivated by heat (Robertson, 1987). In 
addition, serum promotes aneuploidy in cultured cells (Loo et al., 1987) that may 
contribute to the incidence of chromosomal instability in mouse ESCs (Rebuzzini et al., 
2008). In fact, no cell types in vivo are exposed to serum for extended periods, except the 
ones in the vicinity of a wound where clotting has taken place (Barnes and Sato, 1980). 
Because animal serum provides cell culture with many other uncharacterized components 
that may compromise the capability of PSCs to self-renew and differentiate, only 
qualified animal serum can be used for PSC culture (Robertson, 1987). Furthermore, 
animal products cannot be used to maintain human iPSCs for transplantation purposes 
(Ludwig et al., 2006b). Although attempts have been made to culture human ESCs in 
human serum, these cells exhibited extensive differentiation (Rajala et al., 2007). 
Chemically defined culture is a preferable alternative, as it not only allows us to obtain 
more consistent results for better manipulation of PSC differentiation, but can also be 
applied to practical therapeutic uses for iPSCs.  
Serum-free Culture Conditions 
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To eliminate the effects of unknown components in animal serum, chemically defined 
serum-free culture methods have been established for PSCs (Furue et al., 2005; Furue et 
al., 2008; Ludwig et al., 2006b; Ying et al., 2003). Typically, these defined culture media 
are composed of critical growth factors (e.g., LIF and Bmp4) and other factors present in 
animal sera, such as hormones (e.g., insulin and transferring), vitamins, fatty acids and 
minerals. In addition, a pre-mixed serum replacement that claims to include no animal 
serum components was introduced in 1998 (Cheng et al., 2004; Goldsborough et al., 
1998). Although the exact components in the serum replacement cannot be disclosed by 
its patent (Price et al., 1998), the patent indicates that it contains at least albumin, amino 
acids, vitamins, transferrin, antioxidants, insulin, collagen precursors and some trace 
elements. In spite of the fact that the serum replacement successfully supported the 
growth of primate ESCs (e.g., Suemori et al., 2001), human ESCs cultured with this 
preparation indicated the presence of some BMP-like factors that induced the 
differentiation of trophoblasts (Xu et al., 2005b). The maintenance of the undifferentiated 
state of both mouse and human ESCs using defined culture media has been well 
documented (Hayashi et al., 2007; Ludwig et al., 2006a; Ludwig et al., 2006b; Ying et al., 
2008), and the pluripotency of these mouse ESCs has been validated by their 
differentiation in vitro (Furue et al., 2005; Hayashi et al., 2007) and by the development 
of chimeric mice (Ying et al., 2003).  
 
 
 
Tumorigenesis in Pluripotent Stem Cells 
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The ability of cells to grow as a teratoma after transplantation into a host animal is a 
hallmark of cellular pluripotency (see “1.1 Pluripotent stem cells”; Chambers and Smith, 
2004; Damjanov and Andrews, 2007; Jaenisch and Young, 2008; Lensch and Ince, 2007; 
Solter, 2006). Testing this cellular ability requires no special techniques or equipment and 
reduces the use of experimental animals, and it is particularly useful and widely accepted 
for the validation of pluripotency in human PSCs (Yu and Thomson, 2008). However, 
this cellular ability is the major critical safety issue hampering the therapeutic application 
of human iPSCs (Yamanaka, 2009). According to Lawrenz et al. (2004), two mouse 
ESCs were sufficient to grow into a teratoma only when mixed with 2 x 106  non-
tumorigenic fibroblasts (MRC-5) prior to transplantation into immunocompromised mice. 
To date, little is known about the tumorigenic property of PSCs, except that the oncogene 
Eras is responsible for the tumorigenic growth of mouse ESCs (Takahashi et al., 2003). It 
is interesting to note that Eras activates Akt (Takahashi et al., 2003) and that constitutive 
activation of Akt is sufficient to drive self-renewal of mouse and non-human primate 
ESCs (Watanabe et al., 2006). In addition, Akt mediates the inactivation of Gsk3β by 
insulin via phosphorylation (Bechard and Dalton, 2009; Cross et al., 1995; Wu and Pan, 
2010). Gsk3β inhibits its downstream target c-Myc through β-catenin (Bechard and 
Dalton, 2009; He et al., 1998), so Eras may indirectly activate c-Myc, which is 
responsible for the self-renewal of mouse ESCs (Cartwright et al., 2005) and for 
tumorigenesis in mouse iPSCs (Nakagawa et al., 2010; Okita et al., 2007). However, this 
model may involve other uncharacterized gene products, as human ESCs do not express 
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human ERAS (Kameda and Thomson, 2005; Tanaka et al., 2009) but develop into 
teratomas. 
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CHAPTER 2 
Short-term serum-free culture reveals that inhibition of Gsk3β induces the tumor-
like growth of mouse embryonic stem cells 
 
Abstract 
I am presenting evidence that the tumor-like growth of mouse embryonic stem cells ESCs 
is suppressed by short-term serum-free culture, which is reversed by pharmacological 
inhibition of Gsk3β. Mouse ESCs maintained under standard conditions using fetal 
bovine serum (FBS) were cultured in a uniquely formulated chemically-defined serum-
free CDSF medium, namely ESF7, for three passages before being subcutaneously 
transplanted into immunocompromised mice. Surprisingly, the mouse ESCs failed to 
produce teratomas for up to six months, whereas mouse ESCs maintained under standard 
conditions generated a well-developed teratoma in five weeks. Mouse ESCs cultured 
under CDSF conditions maintained the expression of Oct3/4, a master regulator of 
cellular pluripotency. In addition, when mouse ESCs were cultured under CDSF 
conditions supplemented with FBS, or when the cells were cultured under CDSF 
conditions followed by standard culture conditions, they consistently developed into 
teratomas. Thus, these results validate that the pluripotency of mouse ESCs was not 
compromised by CDSF conditions. Mouse ESCs cultured under CDSF conditions 
proliferated significantly more slowly than mouse ESCs cultured under standard 
conditions, and were reminiscent of Eras-null mouse ESCs. In fact, their slower 
proliferation was accompanied by the downregulation of Eras and c-Myc, which regulate 
the tumor-like growth of mouse ESCs. Remarkably, when mouse ESCs were cultured 
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under CDSF conditions supplemented with a pharmacological inhibitor of Gsk3β, they 
efficiently proliferated and developed into teratomas without upregulation of Eras and c-
Myc, whereas mouse ESCs cultured under standard conditions expressed Eras and c-Myc. 
Although the role of Gsk3β in the self-renewal of ESCs has been established, it is 
suggested with these data that Gsk3β governs the tumor-like growth of mouse ESCs by 
means of a mechanism different from the one to support the pluripotency of ESCs.  
 
Introduction 
As summarized in Chapter 1 Literature Review, embryonic stem cells (ESCs; Evans and 
Kaufman, 1981; Martin, 1981; Thomson et al., 1998) and induced pluripotent stem cells 
(iPSCs; Park et al., 2008; Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et 
al., 2007) are very promising tools for use in drug screening and customized tissue 
replacement (Gurdon and Melton, 2008) because they are capable of self-renewal that 
sustains pluripotency. The self-renewal and pluripotency of mouse stem cells ESCs and 
iPSCs are maintained by extrinsic factors, such as supplementing basal culture medium 
with leukemia inhibitory factor LIF (Niwa, 2007; Ohtsuka and Dalton, 2008; Smith et al., 
1988; Tanaka, 2009; Williams et al., 1988) and fetal bovine serum (FBS). However, FBS 
also provides cultures with many other uncharacterized components that may affect the 
capability of ESCs and iPSCs to self-renew and differentiate. Undefined culture 
conditions using animal sera may have contributed to results finding contradictory roles 
of the Wnt signaling pathway in ESCs (Dravid et al., 2005; Lindsley et al., 2006; Sato et 
al., 2004; Ying et al., 2008). However, it is now firmly established that pharmacological 
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inhibition of glycogen synthase kinase 3β Gsk3β promotes the self-renewal of both 
mouse (Bechard and Dalton, 2009; Ying et al., 2008) and human ESCs (Sato et al., 2004), 
and derivation of mouse ESCs (Umehara et al., 2007).  
      To eliminate the effects of unknown components in animal sera as well as the 
contamination of animal products, chemically-defined serum-free culture methods have 
been established (Furue et al., 2005; Furue et al., 2008; Ludwig et al., 2006b; Ying et al., 
2003). Commercially-made serum replacements that may contain animal products 
(Goldsborough et al., 1998) are often used to maintain ESC culture (e.g., Suemori et al., 
2001), although the exact components cannot be disclosed by their patents (Furue et al., 
2008). The maintenance of the undifferentiated state of mouse ESCs using defined 
culture media has been well documented (Hayashi et al., 2007; Ying et al., 2008). 
Furthermore, the pluripotency of these mouse ESCs has been validated by their 
differentiation in vitro (Furue et al., 2005; Hayashi et al., 2007) or by the development of 
chimeric mice (Ying et al., 2003).  
      Another way to validate the pluripotency of ESCs and iPSCs is to examine the ability 
of these cells to develop into tumors called teratomas after their transplantation into 
immunocompromised mice (Chambers and Smith, 2004; Jaenisch and Young, 2008; 
Solter, 2006). Such teratoma formation assays have validated the pluripotency of mouse 
ESCs maintained in the presence of a Gsk3β inhibitor (Sato et al., 2004; Umehara et al., 
2007). This method, which requires no special technique or equipment and reduces the 
use of experimental animals, is particularly useful and widely accepted for the validation 
of pluripotency in human ESCs and iPSCs (Tanaka, 2009; Yu and Thomson, 2008). 
However, their tumor-like growth hampers the therapeutic application of human iPSCs 
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(Yamanaka, 2009). Little is known about the inherent tumorigenic property of ESCs, 
except that the oncogene Eras regulates the tumor-like growth of mouse ESCs via 
activation of Akt1 (Takahashi et al., 2003), which may result in inactivation of Gsk3β 
(Bechard and Dalton, 2009; Cross et al., 1995; Wu and Pan, 2010). However, human 
ESCs do not express human ERAS (Kameda and Thomson, 2005; Tanaka et al., 2009), 
but grow into teratomas (Thomson et al., 1998). Therefore, the underlying mechanism 
involved in the tumor-like growth of ESCs remains unknown. On the other hand, mouse 
ESCs contribute to the development of normal chimeras, instead of forming teratomas, 
when mixed with mouse preimplantation embryos. This finding indicates that mouse 
ESCs require proper extrinsic signals or niches (Voog and Jones, 2010) to differentiate 
normally and to contribute to the development of chimeras. In contrast, mouse ESCs 
exhibit cell death when they are cultured without LIF (Duval et al., 2000; Furue et al., 
2005). This result raises the question of whether mouse ESCs inherently possess the 
tumor-like property or are provided with extrinsic signals that promote their 
tumorigenesis. In this chapter, I present experimental evidence that short-term serum-free 
culture reduces the tumorigenicity of mouse ESCs, which is reversed by pharmacological 
inhibition of Gsk3β. It is suggested with these data that the activity of Gsk3β orchestrates 
the tumor-like growth of ESCs, which may support a novel mechanism independent from 
the one regulating the pluripotency of ESCs. 
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Materials and Methods 
Cell culture 
A mouse embryonic stem cell line of R1 (Nagy et al., 1993), which expresses EGFP 
driven by the Oct3/4 promoter (Viswanathan et al., 2003), was kindly provided by Dr. 
William L. Stanford, University of Toronto, Ontario, Canada (Walker et al., 2007). This 
mouse ESC line was thawed on feeders and maintained under standard (Tompers and 
Labosky, 2004) or chemically-defined serum-free CDSF (Furue et al., 2005) conditions 
at 37 ºC, 5 % CO2. The exact number of passages that this mouse ESC line has gone 
through is unknown. However, when these ESCs were brought to our laboratory, they 
were passaged on feeders two more times and frozen as a stock. When these ESCs were 
thawed on feeders, more frozen stocks were made at passage 5-7. These stocks were used 
for the current study. Under standard conditions, mouse ESCs were maintained on 0.1 % 
gelatin (Sigma-Aldrich, St. Louis, MO, http://www.sigmaaldrich.com)-coated tissue 
culture dishes in high glucose-Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, 
Carlsbad, CA, http://www.invitrogen.com) supplemented with 15 % fetal bovine serum 
(FBS; Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), 2 mM GlutaMax I  
(Invitrogen), 1 mM sodium pyruvate (Invitrogen), 100 units /ml penicillin and 0.1 mg/ml 
streptomycin (Sigma-Aldrich), 0.1 mM 2-Mercaptoethanol (Sigma-Aldrich), and 1,000 
U/ml LIF (Millipore, Billerica, MA, http://www.millipore.com). When the mouse ESCs 
reached 80 % to 100 % confluence, they were routinely passaged at a ratio of 1:6 every 
two days using TrypLETM Express (Invitrogen). The cells were discarded after being 
passaged 10 times onto gelatin-coated dishes. Approximately 1x105 /cm2 mouse ESCs 
maintained under standard conditions were plated onto tissue culture dishes coated with 
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0.15 mg/ml type IA collagen (Nitta Gelatin Co., Osaka, Japan, http://www.nitta-
gelatin.co.jp), which contain the ESF7 medium (Cell Science & Technology Institute Inc. 
Miyagi, Japan, http://www.cstimedia.com; Furue et al., 2005) supplemented with 1,000 
U/ml LIF. This was counted as passage 1 under CDSF conditions. Mouse ESCs at 
passage 7-12 were used to start CDSF culture. Mouse ESCs grown under CDSF 
conditions were split every 3 or 4 days with 0.02 % EDTA Sigma-Aldrich. Similarly, 
mouse ESCs of W4 (129S6, purchased at passage 9; Taconic, Hudson, NY, 
http://www.taconic.com) were used to test CDSF conditions. When CDSF culture was 
supplemented with FBS, 0.02 % EDTA was used for passaging cells. The following 
serum lots were used to supplement CDSF culture: Lot. 1359246 and 726570, Invitrogen; 
Lot. L0228, Atlanta Biologicals (Lawrenceville, GA, http://www.atlantabio.com); Lot. 
A74B00Z, Gemini Bio-Products (West Sacramento, CA, http://www.gembio.com). 
Images of cell morphology and fluorescence were taken under the same conditions using 
an inverted microscope equipped with an epi-fluorescence lamp (DMI4000B, Leica 
Microsystems, Wetzlar, Germany, http://www.leica-microsystems.com). To measure the 
frequency of cell doubling, the mouse ESCs were plated at 1x106 per one well of 6-well 
plates. Two days after plating, the number of cells was counted for the second and third 
passages. Cell doubling was calculated based on the following formula: [Cell 
doubling=log2 (the number of cells 2 days after plating)/(1x106)]. Statistical tests were 
performed using the Mann-Whitney’s U-test.  
 
 
21 
 
Cell transplantation 
At the fourth passage under standard or CDSF conditions, the mouse ESCs were 
trypsinized and counted. TrypLETM Express was inactivated with an equal volume of 1 
mg/ml soybean trypsin inhibitor (Sigma-Aldrich). For this purpose, no culture medium 
with animal serum was used. One to two million cells were centrifuged at 1,000 g for 5 
min and resuspended into 25 µl PBS, which was mixed with 25 µl of 0.3 mg/ml type I 
collagen. Mouse ESCs were kept on ice before being injected into NOD-SCID mice (the 
Jackson Laboratory, Bar Harbor, ME, http://www.jax.org) subcutaneously. Animal health 
was monitored routinely until the diameter of the tumors reached several centimeters at 
which time the animals reached their end points and were euthanized. This procedure was 
approved by the Illinois Institutional Animal Care and Use Committee. The incidence of 
teratoma formation was statistically validated using the Fisher’s exact probability test. 
 
Histology 
Before dissecting the teratomas, pictures of the experimental animals were taken. The 
sizes of the longest axis of the teratomas were measured. Then, the teratomas were 
surgically dissected out, cut into smaller pieces, and fixed in 4 % paraformaldehyde 
(Sigma-Aldrich) at 4 ºC overnight, followed by dehydration and embedding in Paraplast 
plus (Sigma-Aldrich). Sections of 8 µm thickness were cut and processed for standard 
hematoxylin and eosin staining. 
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RT-PCR 
A total of 1.6 µg of total RNA extracted from mouse ESCs cultured under each condition 
was used to synthesize the first cDNA strand as previously described (Tanaka et al., 2008; 
Tanaka et al., 2010). PCR mixtures were prepared using Phusion DNA polymerase (New 
England Biolab, Ipswich, MA, http://www.neb.com) according to the manufacturer’s 
instructions. The PCR conditions were as follows: initial denaturing at 98 ºC for 1 min 
followed by 24 or 25 cycles of denaturing at 98 ºC for 10 sec, annealing at 65 ºC for 30 
sec, extension at 72 ºC for 30 sec, and a final extension at 72 ºC for 7.5 min. The primer 
pairs have previously been described: Eras (Takahashi et al., 2003), Oct4 (Nichols et al., 
1998), Esg1 and Ef1α (Tanaka et al., 2002), Sox2 (Masui et al., 2007), and c-Myc 
(Takahashi and Yamanaka, 2006).  
 
Screening of factors 
A day after mouse ESCs were plated under CDSF conditions, these cultures were 
supplemented with 10 nM retinol (Sigma-Aldrich) in 100 % EtOH with or without 1 nM 
retinol binding protein (RBP) from human urine (Sigma-Aldrich), 10 nM all-trans 
retinoic acid (Sigma-Aldrich), 10 ng/ml Bmp4 (R & D Systems, Minneapolis, MN, 
http://www.rndsystems.com), or 3µM Stemolecule TM  CHIR99021 in DMSO (Stemgent, 
Cambridge, MA, http://www.stemgent.com). Before applying RBP to culture, buffer 
exchange was carried out with Amicon Ultra Millipore to remove a preservative. Mouse 
ESCs grown under these conditions were split with 0.02 % EDTA for 3 passages when 
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they reached confluence. At the fourth passage, these mouse ESCs were injected into 
NOD-SCID mice as described above. 
 
Results 
Mouse Embryonic Stem Cells Reduced their Tumorigenicity but Maintained their 
Pluripotency under Chemically-defined Serum-free Culture  
To examine whether mouse ESCs are destined to grow as teratomas, mouse ESCs were 
cultured in chemically-defined serum-free medium with LIF (referred to  as “CDSF”; 
Furue et al., 2005) for three passages (Fig. 2.1A and C) and subcutaneously transplanted 
them into non-obese diabetic mice with severe combined immunodeficiency disease 
(NOD-SCID) mice (Larochelle et al., 1996). A uniquely formulated serum-free medium, 
ESF7 (see Materials and Methods), was used because components in this medium is fully 
disclosed (Furue et al., 2005). This medium has been used to maintain mouse ESCs by 
other studies (e.g., (Hayashi et al., 2007; Hayashi et al., 2010). However, the pluripotency 
of mouse ESCs cultured under this medium has not been tested by teratoma formation 
assays. Surprisingly, these mouse ESCs failed to grow as teratomas (Fig. 2.1F-H), 
whereas mouse ESCs maintained under standard conditions (Fig. 2.1A and B) grew into a 
well-developed teratoma in 5 weeks (Fig. 2.1F, 2.2A-E and Fig. 2.3A). When mouse 
ESCs were cultured in CDSF supplemented with 15 % FBS (referred to as “CDSF+FBS”; 
Fig. 2.1A and D), they formed a well-developed teratoma in 5 weeks (Fig. 2.1G, 2.2F-J 
and Fig. 2.3B). Thus, tumorigenesis in mouse ESCs is not simply inhibited by CDSF 
conditions. When the injections were properly performed, we did not observe blood 
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coming out of the injection sites. Only properly performed injections were counted in the 
present study. 
      CDSF did not compromise the pluripotency of mouse ESCs per se for the following 
reasons. First, throughout the culture period (three passages, 9-12 days), the 
transcriptional activity of the master regulator of pluripotency, Oct3/4 (Pou5f1; 
(Okamoto et al., 1990; Rosner et al., 1990; Scholer et al., 1990), was validated using a 
mouse ESC line that expresses the enhanced green fluorescent protein (EGFP) under the 
Oct3/4 promoter (Fig. 2.1B and C; Walker et al., 2007). Unless otherwise noted, this 
mouse ESC line was used throughout the present study. Furthermore, when the mouse 
ESC line was maintained in either CDSF+FBS (n=4) or CDSF for three passages and 
brought back to the standard medium for one or two passages (referred to as “CDSF-
Standard”, n=4; Fig. 2.1A), EGFP expression was maintained (Fig. 2.1D and E) and the 
cells became teratomas (Fig. 2.1G and H, and 2.2F- O; p<0.00016, Table 2.1 and Fig. 
2.3B and C). Similar results were obtained using four different lots of FBS. These data 
demonstrate that tumorigenesis in mouse ESCs can be suppressed by short-term culture 
in the serum-free medium. The plasticity of tumorigenicity in mouse ESCs appears to be 
unique; embryonic carcinomas F9 (Bernstine et al., 1973), which are also pluripotent 
stem cells, formed teratomas when cultured in CDSF and transplanted (Fig. 2.3D). 
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Mouse Embryonic Stem Cells Cultured under Serum-free Conditions Exhibited 
Longer Doubling Time while Maintained Expression of Genes Associated with 
Cellular Pluripotency  
When NOD-SCID mice transplanted with mouse ESCs reached their end points, they 
were sacrificed and examined for teratomas. This procedure usually yielded teratomas of 
about 30 mm in diameter (bars in Fig. 2.4A). However, the number of days needed for 
the experimental animals to reach their end points varied (dots in Fig. 2.4A). Interestingly, 
it took 47 ± 3.1 days for mouse ESCs cultured in CDSF+FBS to grow into 30 mm 
teratomas, whereas it took 37 ± 1.8 days for mouse ESCs cultured in CDSF followed by 
standard conditions for two passages to reach 30 mm in diameter. However, when mouse 
ESCs cultured in CDSF were passaged only once into standard conditions, it took 76 
days for these mouse ESCs to grow into a 30 mm teratoma. Although this sample size is 
too small to be statistically significant, it is suggested with these data that CDSF may 
even suppress the growth of teratomas.  
      Among the experimental NOD-SCID mice examined in this study, two out of the 
seven mice had mouse ESCs cultured in CDSF injected into one side of the animal and 
mouse ESCs cultured in media containing FBS injected into the other side. Therefore, the 
formation of teratomas from mouse ESCs cultured in CDSF could not be examined 
beyond the end point of the animals (Fig. 2.4A). However, in the other five animals, we 
were able to determine that transplanted mouse ESCs under CDSF did not generate 
teratomas for up to 6 months. This examination is ongoing.  
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      At one injection site, we were able to identify a tiny mass of mouse ESCs that had 
been cultured under CDSF-Standard conditions one week after transplantation (Fig. 2.3E). 
The mouse ESCs in this mass had the appearance of cells undergoing initial 
differentiation (Fig. 2.5). However, we did not observe any cellular mass at the injection 
sites that were derived from mouse ESCs cultured in CDSF at either one week or six 
months after transplantation. 
      Mouse ESCs cultured in CDSF exhibited a significantly longer doubling time (~28 
hrs) than ones cultured under standard conditions (~17 hrs, p<0.005) during the first two 
passages, whereas ones cultured in CDSF+FBS or under CDSF-Standard conditions took 
~19 and ~20 hrs to divide, respectively (Fig. 2.4B, top). Similar results were obtained 
with another mouse ESC line, W4 (Auerbach et al., 2000; Raz et al., 1999) (data not 
shown). The differences in doubling times of mouse ESCs were evident as soon as two 
days after transfer to CDSF conditions (1.91 doublings ± S.E.M. of 0.0967 vs. 2.72 
doublings ± S.E.M. of 0.0923 for the standard condition in 48 hrs, p<0.005). Despite the 
longer doubling time, mouse ESCs cultured in CDSF did proliferate steadily (Fig. 2.4B, 
bottom). Additionally, transcripts associated with cellular pluripotency, Sox2, 
Esg1/Dppa5 and Oct3/4, were expressed in mouse ESCs cultured in CDSF (Fig. 2.4C). 
Interestingly, Eras, which regulates the tumorigenic growth of mouse ESCs (Takahashi et 
al., 2003), was downregulated in these mouse ESCs (Fig. 2.4C), whereas it became 
upregulated when mouse ESCs were maintained in CDSF+FBS or under CDSF-Standard 
conditions (Fig. 2.4C). Collectively, the loss of tumor-like potential in mouse ESCs 
cultured under CDSF is associated with a slower growth rate and the reduced expression 
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of Eras. It is interesting to note that Eras-null mouse ESCs can contribute to the germline 
in chimeric animals but show significantly reduced growth rate (Takahashi et al., 2003). 
 
Pharmacological Inhibition of Gsk3β Reversed the Effect of Serum-free Culture on 
the Tumor-like Growth of Mouse Embryonic Stem Cells 
To identify a potential serum factor responsible for inducing the tumor-like growth in 
mouse ESCs, initially we focused on molecules known to sustain the self-renewing 
growth of mouse ESCs, such as LIF (Smith et al., 1988; Williams et al., 1988), Bmp4 
(Ying et al., 2003), vitamin A derivatives (all-trans retinoic acid, RA; Wang et al., 2008) 
and retinol; (Chen and Khillan, 2008; Chen and Khillan, 2010), and simultaneous 
inhibition of Gsk3β and Erk (Ying et al., 2008). Pharmacological inhibition of Gsk3β 
alone promotes self-renewal of both mouse and human ESCs (Sato et al., 2004). We 
excluded LIF from screening because CDSF contains LIF (Furue et al., 2005). In the 
absence of LIF, mouse ESCs undergo differentiation or cell death (Duval et al., 2000; 
Furue et al., 2005). We also ruled out an inhibitor of Erk (Ying et al., 2008), which acts 
downstream of FGF receptors, because inhibition of Erk cannot promote the growth of 
mouse ESCs (Ying et al., 2008). Therefore, we focused on testing other molecules such 
as Bmp4, RA, retinol with or without retinol binding protein (RBP) (Soprano and Blaner, 
1994), and an inhibitor of Gsk3β (CIHR99021; Ying et al., 2008).  
      Addition of RA in CDSF induced differentiation of mouse ESCs as evidenced by the 
reduced expression level of EGFP (Fig. 2.6A). Addition of retinol with or without RBP in 
CDSF did not induce differentiation of mouse ESCs (Fig. 2.6B and C), but failed to 
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accelerate their growth and to induce teratoma formation (Fig. 2.7A and B). In contrast, 
mouse ESCs cultured in CDSF with Bmp4 or the Gsk3β inhibitor maintained Oct3/4 
expression (Fig. 2.6D and E), increased the number of cell doublings (Fig. 2.7A) and 
formed teratomas in 17 % or 67 % of transplantations by 7 months, respectively (Fig. 
2.7B and C, and Fig. 2.3F and G). Also, W4 mouse ESCs exhibited similar phenotypic 
changes when maintained in CDSF with the Gsk3β inhibitor (Fig. 2.7B; the one with n.d. 
is from W4 cell line). Gsk3β is known to regulate the activity of the c-Myc protein in 
mouse ESCs (Bechard and Dalton, 2009; Cartwright et al., 2005). However, RT-PCR 
analysis showed that inhibition of Gsk3β did not result in upregulation of Eras and c-Myc 
in mouse ESCs cultured in CDSF, whereas Bmp4 induced upregulation of Eras and c-
Myc (Fig. 2.7D).  
 
Discussion 
In this chapter, I present experimental evidence to suggest that short-term CDSF culture 
reduces the tumor-like growth of mouse ESCs, which is reversed by pharmacological 
inhibition of Gsk3β. The present study indicates that downstream of Gsk3β is primarily 
responsible for tumorigenesis in mouse ESCs, which may involve uncharacterized gene 
products. Although the exact mechanism currently remains unknown, our present study 
provides a basis for further study to establish the signaling pathway responsible for the 
tumor-like property of ESCs.  
      In general, serum provides hormones, growth factors, and steroids to cultured cells. It 
also contains remnants of plasma components used for the activation and processing of 
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blood clots and substances that do not normally pass through the endothelial barrier 
(Hewlett, 1991; Holliday, 1999; Sato et al., 2010). Therefore, serum is similar but not 
identical to the interstitial fluid (i.e., lymph) that surrounds cells in vivo (Sato, 1975). No 
cellular mass was observed at the injection sites, which were derived from mouse ESCs 
cultured in CDSF at either one week or six months after transplantation. Therefore, it is 
suggested with these data that interstitial fluid will not support the tumor-like growth of 
mouse ESCs.  
      Perhaps mouse ESCs cultured under short-term CDSF conditions became more 
susceptible to LIF and exhibited cell death after transplantation due to the absence of a 
continuous supply of LIF (Furue et al., 2005). However, because each mouse ESC line 
shows a different degree of LIF dependency (Raz et al., 1999), other mouse pluripotent 
stem cells cultured in the serum-free medium may exhibit a capability to continuously 
grow after transplantation, as observed in embryonic carcinomas (F9; Fig. 2.3D). In 
addition, the formation of teratomas became sporadic when 0.5 x 106 mouse ESCs 
cultured under standard conditions were transplanted for a period of 6 months. 
Collectively, this study demonstrated that one or more extrinsic factors or niche (Voog 
and Jones, 2010) plays an important role in the formation of a teratoma. This idea is 
further supported by the fact that two mouse ESCs were sufficient to grow into a 
teratoma only when mixed with 2 x 106 non-tumorigenic fibroblasts (MRC-5) prior to 
transplantation into immunocompromised mice (Lawrenz et al., 2004). Interestingly, the 
slow growth observed in Eras-null mouse ESCs became more evident when they were 
cultured without feeder cells (Takahashi et al., 2003). 
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      These data indicate that animal sera contain one or more factors that inhibit the 
activity of the Gsk3β protein (Fig. 2.1 and 2.7). Gsk3β is involved in the canonical Wnt 
signaling pathway (Doble and Woodgett, 2003; Jope and Johnson, 2004; Wu and Pan, 
2010) and interacts with other biologically important signaling pathways such as 
Phosphoinositide 3-kinase (PI3K)-Akt1 (Cross et al., 1995; Paling et al., 2004; Watanabe 
et al., 2006), Bmp4 (Itasaki and Hoppler, 2010) and hedgehog (Kim et al., 2009; Riobo et 
al., 2006; Zhang et al., 2005) signaling pathways. Although the secreted protein Wnt 
eventually inhibits the activity of Gsk3β, the role of Wnt in the maintenance of self-
renewal and pluripotency of ESCs remains elusive (Dravid et al., 2005; Lindsley et al., 
2006; Sato et al., 2004; Ying et al., 2008). On the other hand, pharmacological inhibition 
of Gsk3β supports the self-renewal and pluripotency of ESCs (Bechard and Dalton, 2009; 
Sato et al., 2004; Umehara et al., 2007; Ying et al., 2008). Now, the question is what 
Gsk3β upstream and downstream genes are active in self-renewing ESCs.  
      Both LIF-Stat3 (Matsuda et al., 1999; Niwa et al., 1998) and insulin pathways 
activate the PI3K-Akt1 signaling pathway (Bechard and Dalton, 2009; Paling et al., 
2004), which mediates the inactivation of Gsk3β (Bechard and Dalton, 2009; Cross et al., 
1995; Wu and Pan, 2010). However, CDSF includes LIF and insulin (Furue et al., 2005), 
and failed to support the tumor-like growth of mouse ESCs (Fig. 2.1 and 2.4). Thus, LIF 
and insulin are not upstream of Gsk3β. Because Eras activates Akt1 (Takahashi et al., 
2003), the downregulation of Eras in mouse ESCs cultured in CDSF (Fig. 2.4C and 2.7D) 
may have resulted in the activation of Gsk3β. However, human ESCs do not express 
human ERAS but they do grow into teratomas (Kameda and Thomson, 2005; Tanaka et 
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al., 2009). Because this signaling cascade is not evolutionarily conserved, Eras is not 
upstream of Gsk3β.  
      Based on our results, Bmp4 poorly promoted proliferation and teratoma formation of 
mouse ESCs cultured under CDSF conditions (Fig. 2.7A and B). It is well known that the 
Bmp4 and Wnt signals interact with each other in many morphogenetic events, which 
could result in either synergistic or antagonistic effects depending on cell types (Itasaki 
and Hoppler, 2010). Because of the following two observations, we consider the effect of 
Bmp4 on Gsk3β or the tumor-like growth of mouse ESCs antagonistic or indirect. First, 
our RT-PCR results revealed that mouse ESCs cultured in CDSF supplemented with 
Bmp4 efficiently upregulated oncogenes Eras and c-Myc, which was not the case in 
mouse ESCs treated with the Gsk3β inhibitor (Fig. 2.7D). Second, in one set of these 
experiments, Bmp4 efficiently induced formation of teratomas when ESCs at the earlier 
passage number (passage 7) were used for the culture (see ii in Fig. 2.7B). In contrast, 
when mouse ESCs at passage 9 or later were cultured in CDSF with Bmp4 and 
transplanted, they sporadically developed into teratomas. Taken together, further 
investigation is required to determine upstream of Gsk3β in ESCs.  
      It is interesting to note that in concert with LIF, Bmp4 suppresses differentiation of 
the neural lineage in mouse ESCs maintained under serum-free conditions (Ying et al., 
2003) supplemented with N2 and B27, which were originally developed to culture a 
neuroblastoma cell line (Bottenstein and Sato, 1979) and hippocampal neurons (Brewer 
et al., 1993), respectively. Mouse ESCs maintained under serum-free conditions 
supplemented with LIF, Bmp4, N2 and B27 are pluripotent and can contribute to the 
germline in chimeric animals (Ying et al., 2003). On the other hand, our current study 
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demonstrated that both the CDSF medium used in the present study, which contains LIF, 
and the CDSF medium supplemented with Bmp4 poorly sustained the tumor-like growth 
of mouse ESCs. Therefore, it is suggested with these data that the cellular pluripotency 
and the tumor-like growth of ESCs may be regulated by different mechanisms.  
      Gsk3β inhibits the activity of its target c-Myc (Bechard and Dalton, 2009; He et al., 
1998), which is involved in the self-renewal of mouse ESCs (Cartwright et al., 2005) and 
responsible for an age-associated incidence of tumorigenesis in chimeric mice generated 
with mouse iPSCs (Nakagawa et al., 2010; Okita et al., 2007). In contrast, our RT-PCR 
results showed that mouse ESCs cultured under CDSF conditions with the Gsk3β 
inhibitor failed to significantly upregulate transcription of Eras and c-Myc (Fig. 2.7D) but 
efficiently developed into teratomas (Fig. 2.7B and C). Thus, Gsk3β downstream genes 
other than c-Myc may regulate the tumor-like growth of ESCs, which play independent 
roles from maintaining the self-renewal of ESCs. In addition, candidate Gsk3β 
downstream genes responsible for tumorigenesis in mouse ESCs may act independently 
from ERAS in human ESCs (Kameda and Thomson, 2005; Tanaka et al., 2009). Further 
study to identify the candidate genes and to test their roles in human ESCs and iPSCs will 
lead us to establishing a strategy to significantly improve the safety of human iPSCs.  
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Figures 
 
Figure 2.1. The tumorigenicity of mouse embryonic stem cells can be reduced by 
short-term serum-free culture. (A): A mouse embryonic stem cell ESC line harboring 
an EGFP driven by the Oct3/4 promoter was maintained in either standard or chemically-
defined serum-free (CDSF) medium as indicated. (B-E): Phase contrast (left) and 
fluorescence (right) images of the ESC line under the conditions indicated above are 
shown. Bars, 20 µm. (F-H): After the mouse ESCs were cultured as indicated, they were 
transplanted into NOD-SCID mice subcutaneously. Teratoma formation was observed by 
week 11. Bars, 1 cm.  
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Figure 2.2. Identification of three germ layers in teratomas. (A-E): Teratomas 
developed from mouse ESCs cultured under standard conditions. (F-J) : Teratomas 
developed from mouse ESCs cultured in CDSF supplemented with 15% FBS 
(CDSF+FBS). (K-O): Teratomas developed from mouse ESCs cultured in CDSF 
followed by transfer to standard conditions (CDSF to Stand.) Ectoderm is represented by 
neural tissue and keratin pearl, mesoderm is represented by cartilage and striated muscle, 
and endoderm is represented by ciliated epithelium. Bars, 20 µm.  
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Figure 2.3. Anatomical images of NOD-SCID mice transplanted with mouse 
embryonic stem cells. (A-D, F and G): Teratomas developed from mouse ESCs and 
embryonic carcinomas (F9 in D) cultured under the conditions indicated are shown.  Also, 
the number of weeks (wks) needed for the experimental animals to reach their end points 
are shown. Bars, 1cm. CDSF+FBS, CDSF culture supplemented with fetal bovine serum; 
CDSF-Standard, CDSF conditions followed by standard conditions; CDSF (F9), 
embryonic carcinoma cells F9 maintained under CDSF conditions; CDSF+Bmp4, CDSF 
culture supplemented with Bmp4; CDSF+iGsk3β, CDSF culture supplemented with the 
Gsk3β inhibitor. (E): This animal was sacrificed one week after mouse ESCs cultured 
under CDSF conditions followed by standard conditions were transplanted. The rectangle 
indicates the area shown in the inset. Bar, 1cm. The inset shows an enlarged image of a  
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Figure 2.3 (cont.) 
tiny mass of the mouse ESCs depicted by dashed lines with a scale bar of 0.1 cm. See 
supplemental information Fig. 2 for detail.  
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Figure 2.4. Phenotypic changes observed in mouse embryonic stem cells cultured 
under CDSF conditions. (A): The sizes of the teratomas formed (orange bar, left axis) 
and the number of days required for the experimental NOD-SCID mice to reach their end 
points (blue stars, right axis) were compared among mouse ESCs cultured under the 
conditions indicated (see Fig. 2.1A). Parentheses indicate the number of biological 
replicates (i.e., moue ESCs prepared at different passages) per culture condition. Standard 
errors of the means are indicated by bars. a: Only one passage in standard conditions 
followed CDSF culture. b: Two out of seven transplantations showed no sign of teratoma 
formation when paired with the standard and CDSF-Standard conditions, whereas five 
out of seven transplantations showed no sign of teratoma formation for 6 months. (B, top): 
Cell doublings were measured every 48 hours after plating 1x 106 cells per well onto 6- 
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Figure 2.4 (cont.) 
well plates (see Materials and Methods for the formula). Only CDSF conditions produced 
statistically-significant differences compared to standard conditions. Parentheses indicate 
the number of biological replicates per condition. Standard errors of the mean are 
indicated by bars. (B, bottom): Phase contrast (top) and fluorescence (bottom) images are 
shown for the Oct3/4::EGFP mouse ESC line (Fig. 2.1A) grown under the conditions 
indicated below 1 and 2 days after plating 0.1x106 cells per well in 6-well plates. Bars, 50 
µm. (C): Abundance of each transcript indicated above was examined in mouse ESCs 
cultured under each condition on the right by 25 cycles of PCR. Ef1α was used as a 
reference. 
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Figure 2.5. Mouse embryonic stem cells exhibited initial differentiation as early as 
one week after transplantation when cultured under CDSF-standard conditions. 
Mouse ESCs were cultured in CDSF for three passages followed by transfer to standard 
conditions for two passages prior to transplantation. (A): An epithelialized cellular mass 
has aggregates formed among the collagen fibers (stained pale pink) used to transplant 
the mouse ESCs. Rectangles indicate the areas shown in B, C and D. Bar, 500 µm. (B-D): 
Two types of cells are prominent, one of which is reminiscent of keratin pearls (B and D), 
and the other that resembles cartilage (C and D). Bars, 20 µm. 
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Figure 2.6. Identification of factors that support the tumor-like growth of mouse 
embryonic stem cells maintained under CDSF conditions. (A-E): Phase contrast (top) 
and fluorescence (bottom) images of mouse ESCs under CDSF conditions supplemented 
with each factor indicated above are shown. Bars, 20 µm. CDSF+RA, CDSF with 
retinoic acid; CDSF+RL, CDSF with retinol; CDSF+RL+RBP, CDSF with retinol and 
retinol binding protein; CDSF+Bmp4, CDSF with Bmp4; CDSF+iGsk3β, CDSF with the 
Gsk3β inhibitor. 
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Figure 2.7. Screening of factors responsible for the tumor-like growth of mouse 
embryonic stem cells. (A): Cumulative numbers of mouse ESCs were compared among 
ESCs cultured under each condition indicated for 3 passages. Cell counts were 
normalized to CDSF conditions. A value for CDSF conditions is normalized to 1. 
Parentheses indicate the number of biological replicates per condition. Standard errors of 
the mean are indicated by bars. +RA, CDSF with retinoic acid; +RL, CDSF with retinol; 
+RL+RBP, CDSF with retinol and retinol binding protein; +Bmp4, CDSF with Bmp4; 
+iGsk3β, CDSF with the Gsk3β inhibitor. (B): Total numbers of biological replicates that 
resulted in formation of teratomas were compared among mouse ESCs cultured under  
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Figure 2.7 (cont.) 
each condition indicated. Orange and yellow boxes indicate the number of biological 
replicates that developed into teratomas within 3 months and in more than 6 months, 
respectively. Blue bars indicate the number of biological replicates that failed to form 
teratomas for more than 6 months. Data for the Gsk3β inhibitor include results obtained 
with R1 and W4 mouse ESCs. For those biological replicates indicated as (i), (ii) and (iii) 
in the bar chart, the number of technical replicates, the number of days needed for the 
experimental animals to reach their end points, and the sizes of the longest axis of the 
teratomas are shown per technical replicate. Asterisks (*) indicate that the growth of the 
teratoma is ongoing. n.d., not determined. (C, top): NOD-SCID mice that received 
transplantation of mouse ESCs cultured in CDSF supplemented with Bmp4 (right) or the 
Gsk3β inhibitor (left) are shown. Bars, 1 cm. (C, bottom): Representative histological 
images are shown. The presence of three germ layers (see the legend for Fig. 2.2) is 
evident in teratomas developed from mouse ESCs cultured in CDSF supplemented with 
the Gsk3β inhibitor. Bars, 20 µm. (D): Abundance of each transcript indicated above was 
examined in mouse ESCs cultured under each condition on the right by 24 cycles of PCR. 
Ef1α was used as a reference. 
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Table 2.1. Effects of serum on the tumorigenicity of mouse embryonic stem cells. 
Conditions # of Biological 
replicates 
Teratomas 
formed 
 
CDSF  7  0 p=0.0001554a
With FBS  8  8  
 CDSF+FBS  4  4  
 CDSF to 
Stand. 
 4  4  
a: Compared with conditions “with FBS”.  
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CHAPTER 3 
Gli2 expression is associated with the tumorigenicity of mouse embryonic stem cells 
 
Abstract 
Here, I present experimental evidence that Gli2 expression is associated with the tumor-
like growth of mouse ESCs. By global gene expression profiling of mouse ESCs, 
surprisingly I found that the oncogene Gli2, a downstream target of the growth factor 
Sonic hedgehog (Shh), was expressed in undifferentiated mouse ESCs, which was further 
validated by semi-quantitative RT-PCR and immunofluorescent microscopy. It is well-
known that the Gli2 protein is activated by Shh. However, interestingly, the Gli2 
transcripts were expressed abundantly in mouse ESCs without endogenous Shh 
expression detected. To test if expression of Gli2 in mouse ESCs is based on the 
autonomous mechanism or due to a signal(s) from the extracellular environment, mouse 
ESCs were cultured in either standard or CDSF conditions for 3 passages. Mouse ESCs 
maintained in these conditions showed similar levels of Oct3/4 expression. However, 
intriguingly, mouse ESCs maintained under CDSF conditions downregulated Gli2 as well 
as Eras, another oncogene responsible for the tumor-like growth of mouse ESCs, and 
reduced their capability to grow into teratomass. In contrast, a teratocarcinoma cell line 
F9 maintained expression of Gli2 and Eras expression as well as its capability to grow 
into teratomas even when F9 was cultured under CDSF condtitions. When cultured under 
CDSF conditions supplemented with FBS or CDSF conditions brought back to standard 
conditions, mouse ESCs upregulated Gli2, and efficiently grew into teratomas. 
Surprisingly, when an inhibitor of Gsk3β was added in CDSF conditions, mouse ESCs 
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enhanced their tumor-like growth, and upregulated Gli2 expression. These findings 
indicate that Gli2 expression is tightly correlated with the incidence of tumor-like growth 
of mouse ESCs.  
 
Introduction 
As described in Chapter 1 Literature Review, the underlying mechanisms of 
transcriptional heterogeneity as well as the tumor-like growth in mouse embryonic stem 
cells (ESCs) remain unknown. Without elucidating the molecular basis of these 
mechanisms, application of human iPSCs to the practical therapeutic use will be difficult. 
Toward a better understanding of the self-renewal of mouse ESCs, our laboratory has 
surveyed  global gene expression profiles of mouse ESCs (Tanaka, 2009; Walker et al., 
2007) and compared them with other published data (Matoba et al., 2006). Interestingly, 
this bioinformatical analysis has identified that the transcription factor Gli2 is 
consistently highly expressed in undifferentiated mouse ESCs and becomes 
downregulated during their differentiation.   
      Originally, Gli1 was identified due to its amplification in human glioblastomas 
(Kinzler et al., 1988). Vertebrates have two more homologues of Gli1, namely Gli2 and 
Gli3, which are also expressed in human glioblastomas (Clement et al., 2007). Later, Gli 
proteins were identified as the orthologue of the zinc-finger transcription factor cubitus 
interrprus Ci in Drosophila, which acts downstream of the Hedgehog Hh signaling 
pathway (Ingham and McMahon, 2001). 
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The gene encoding Hedgehog Hh was first discovered by screening Drosophila 
mutant larvae that exhibited defects in their body plan (Nusslein-Volhard and Wieschaus, 
1980). Due to the appearance of mutant larvae having short and spiked cuticles, Nusslein-
Volhard and Wieschaus named the gene responsible for this phenotype Hedgehog. Mouse 
Hh orthologs were cloned in 1993. Unlike Drosophila, the mouse has three orthologs of 
Hh, which are named after characters found in Nintendo “Sonic the hedgehog”, Desert 
hedgehog Dhh, Indian hedgehog Ihh and Sonic hedgehog Shh (Echelard et al., 1993). 
Similarly, Hh orthologs were found in other vertebrates, such as rat (Roelink et al., 1994) 
and human (Marigo et al., 1995). 
The Hh signal is transmitted through two transmembrane receptors, Patched Ptc and 
Smoothened Smo (Ingham and McMahon, 2001). Without the ligand Hh, Ptc binds to 
Smo and represses the activity of Smo (Taipale et al., 2002). When Hh binds to Ptc, this 
results in repression of the Ptc activity, which subsequently promotes release of Smo. 
Then, Smo translocates into nuclei, activates the protein activity of the transcription 
factor Gli and regulates transcription of downstream targets of the Hh pathway (Stone et 
al., 1996; Taipale et al., 2002) (Fig. 3.2A).  
      Each Gli protein has a unique role in neurogenesis and skeletal patterning in a context 
dependent manner (Ruiz i Altaba et al., 2007). Gli1 and Gli2 play the major role as 
transcriptional activators in ectopically activated Shh signals (Bai et al., 2002) and Gli2 
can be expressed in the absence of the Shh signal (Bai and Joyner, 2001; Ruiz i Altaba, 
1998). Gli3 mostly acts as a transcriptional repressor (Ruiz i Altaba et al., 2007).  
Transcriptional upregulation of Gli1 and Ptc indicates that the Hh pathway is active 
(Shaw et al., 2009).  
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The role of the Hh signal has been extensively investigated in neural stem cells (Ahn 
and Joyner, 2005; Balordi and Fishell, 2007; Palma et al., 2005) and hematopoietic stem 
cells (Dierks et al., 2008; Jiang et al., 2008).  However, biological significance of the Hh 
function is less studied in embryonic stem cells. Recombinant mouse Shh proteins can 
stimulate the proliferation of mouse ESCs in concert with other pathways, such as 
epidermal growth factor (EGF) and Wnt (Heo et al., 2007), whereas recombinant human 
SHH proteins have failed to maintain the self-renewal of human ESCs (Wu et al., 2009). 
Therefore, the role that the Hh signal plays in ESCs remains elusive.  
 
 
Materials and Methods 
Microarray analysis 
First, a mouse embryonic stem cell line, namely OVW4, which expresses the puromycin 
resistant gene under the Oct3/4 promoter (Yeom et al., 1996) was generated . Then, 
OVW4 was plated at 100 cells/cm2 and maintaind under the presence or the absence of 
puromycin (2 µg/ml; Invivogen) for 5 days. Total RNA was extracted from three 
biological replicates of each condition, and subjected to Illimina microarray analysis. A 
list of differentially expressed genes with less than 0.05 of the false discovery rate (FDR) 
at the expression level of 200 or higher was generated. Then, the list of genes was 
compared  with other published data (Matoba et al., 2006) by ConPath Navigator (DNA 
Chip Research Inc.). 
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Cell culture  
The mouse embryonic stem cell lines (R1 and W4) were cultured under standard and 
CDSF conditions as described in Chapter 2. Teratocarcinoma cell lines of mouse (F9 and 
P19) and human (NTERA-2) were cultured under standard conditions for mouse ESCs 
without LIF, because they are not dependent on LIF. NTERA-2 cells (kindly provided by 
Dr. Fei Wang, UIUC) were expanded by cell scrapers. F9 and P19 were also cultured in 
CDSF conditions as the mouse ESCs. Human ESCs (H1; WiCell) were cultured on BD 
MetrigelTM (StemCell Technologies Inc)-coated 6-well tissue culture plate with 
mTeSRTM1 (StemCell Technologies Inc) medium at 37 ºC, 5 % CO2. When cells reached 
confluence, 1 mg/ml dispase (StemCell Technologies Inc) was used to incubate the cells 
at 37 ºC for 7 min, followed by 3 times washes with DMEM/F12 (Invitrogen). Cells were 
dislodged by 5 ml pipettes, centrifuged at 300 g for 5 min, and then resuspended with 
mTeSRTM1 medium.   
 
RT-PCR 
RT-PCR was carried out as already described in Chapter 2. The primer sets used for this 
study are listed on Table 3.1. 
 
Immunofluorescent microscopy 
After fixation with 4% paraformaldehyde (Sigma) in PBS at room temperature for 15 min, 
mouse ESCs cultured on glass-bottom dishes (MatTek corporation) were washed with 
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PBS, and blocked with 0.1% Triton-X-100 at room temperature for 10 min. After similar 
PBS washes, these mouse ESCs were incubated with 10% Image-iT FX signal enhancer 
(Invitrogen) at room temperature for 30min, followed by incubation with mouse anti-
human Oct4 monoclonal antibody (Santa Cruz) and rabbit anti-human Gli2 polyclonal 
antibody (Abcam) diluted with 10% Image-iT FX signal enhancer at the 1:200 ratio at 
4 °C overnight. After PBS washes, samples were incubated with goat Alexa Fluor 488 
anti-mouse IgG and goat Alexa Fluor 568 anti-rabbit IgG diluted in 10% Image-iT in 
PBS at room temperature for 1 hour. Cellular nuclei were stained with Hoechst after 
similar PBS washes. These immunostained mouse ESCs were treated with ProLong Gold 
antifade reagent (Invitrogen). The confocal microscope LSM 700 was used. 
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Results 
 
Undifferentiated Mouse and Human Embryonic Stem Cells Express Gli2 
To understand the mechanism of cell fate decision in embryonic stem cells (ESCs), we 
have surveyed global gene expression profiles of mouse ESCs (Tanaka, 2009; Walker et 
al., 2007) and compared them with other published data (Matoba et al., 2006). 
Surprisingly, this bioinformatical analysis showed that the transcription factor Gli2 was 
consistently highly expressed in undifferentiated mouse ESCs and became downregulated 
during their differentiation, while the Gli3 expression pattern was opposite (Fig. 3.1A). 
When all-trans retinoic acid (RA) was supplemented in the culture medium without LIF 
to promote neural differentiation, Gli2 expression became upregulated, consistent with 
the role of Gli2 in neural development (Fig. 3.1B). 
To validate our analysis of global gene expression profiles in mouse ESCs, we 
examined expression of Gli2, together with other genes downstream of Shh in 
undifferentiated and differentiated mouse ESCs (R1; Fig. 3.2B) and undifferentiated 
human ESCs (H1; Fig. 3.2C) by semi-quantitative reverse-transcriptase polymerase chain 
reaction (RT-PCR). Similar Gli2 and Gli3 expression patterns were confirmed in mouse 
ESCs (Fig. 3.2B). Expression of Gli1 and Ptc in undifferentiated ESCs indicates that Shh 
signaling was stimulated (Fig. 3.2B). Expression of genes downstream of Shh except Smo 
was downregulated when mouse ESCs were differentiated (Fig. 3.2B). In undifferentiated 
human ESCs, expression of GLI2 was also detected, but GLI3 exhibited a higher level of 
expression than in undifferentiated mouse ESCs (Fig. 3.2C). This discrepancy may be 
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attributed to the difference of culture conditions and the degree of cellular pluripotency 
between mouse and human ESCs. It is suggested with these results that Gli2 may be 
essential to sustain the undifferentiated state of ESCs. However, this suggestion is 
unlikely because Gli2-deficient embryos showed defects in body plans but not in cell 
differentiation per se (Mo et al., 1997).  
To further validate our microarray analysis and test whether the Gli2 protein is 
present in undifferentiated mouse ESCs, immunofluorescent microscopy was conducted, 
because it is suggested with our array analysis that Gli2-positive and negative cells may 
exist among a population of undifferentiated mouse ESCs. Confocal microscopy was 
employed to remove ambiguity because mouse ESCs overlap within the colonies. The 
majority of the Gli2 protein was localized in nuclei which exhibited a patchy staining 
pattern, and that Gli2-positive mouse ESCs were also undifferentiated and Oct3/4-
positive (Fig. 3.3). In addition, the mouse ESCs showing the higher level of Gli2 protein 
also showed the higher level of Oct3/4 protein (Fig. 3.3).  
 
Mouse ESCs Receives the Shh Signal from Culture Microenvironment 
Expression of Gli1 and Ptc indicates the activation of the Shh signal. Surprisingly, Gli1 
and Ptc are abundantly expressed in undifferentiated mouse ESCs cultured under 
standard conditions, but there is no detectable endogenous Shh expression in mouse ESCs 
(Fig. 3.4 upper line). To investigate whether mouse ESCs receives some signals from the 
culture microenvironment, or autonomously express genes downstream of Shh, the same 
mouse ESCs were cultured in the chemically defined serum-free conditions (CDSF) as 
52 
 
described in Chapter 2. They were passaged 3 times under CDSF conditions before 
processed for RT-PCR. The CDSF medium we used does not contain any components 
that could induce Shh singling such as Vitamin A and TGFβ (Dennler et al., 2007; Riddle 
et al., 1993). Intriguingly, Gli2 became undetectable when mouse ESCs were cultured 
under CDSF conditions, whereas these mouse ESCs maintained a similar level of Oct3/4 
expression to the ones under standard conditions (Fig. 3.4 bottom line). This result 
indicates that upregulation of Gli2 is triggered by some factors present in standard culture 
conditions. The downregulation of Gli2 expression was accompanied with 
downregulation of Eras (Fig. 3.4), which is responsible for the tumor-like growth of 
mouse ESCs (Takahashi et al., 2003). As discussed in Chapter 2, these mouse ESCs 
cultured under CDSF conditions failed to generate teratomas up to 6 months. Thus, these 
findings indicate that one or more factors in animal serum activated Gli2 in mouse ESCs, 
which make them tumorigenic. Furthermore, we found that supplementing CDSF 
conditions with recombinant mouse Shh (100 ng/ml or 500 ng/ml; Fig. 3.5A) failed to 
promote proliferation (Fig. 3.5B and C) and rescue the tumorigenicity of mouse ESCs 
(Fig. 3.5D), even though the expression of Gli2 is restored (data not shown), which led us 
to hypothesize that there are factors synergizing with Shh in the standard culture 
microenvironment, which trigger the Gli2 expression and tumor-like growth of mouse 
ESCs.   
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Gli2 Expression may Serve as a Novel Marker of Tumorigenic Growth of Mouse 
ESCs 
To test whether expression of Gli2 is associated with the tumor-like growth of pluripotent 
stem cells, teratocarcinoma cell lines of mouse (F9, testicular; P19, from postimplantation  
embryos) and human (NTERA-2, testicular), which are transplantable, malignant 
teratocarcinoma, were used. F9, P19 (Fig. 3.6) and NTERA-2 (data not shown) showed 
Gli2 expression when cultured under standard conditions. Also F9 and P19 maintained 
expression of Gli2 and Eras when cultured under CDSF conditions (Fig. 3.7), and that F9 
cultured under CDSF conditions generated a well-developed teratoma within 4 weeks. 
Thus, CDSF conditions themselves have no negative effects on proliferation of cultured 
pluripotent stem cells. When mouse ESCs were cultured under CDSF conditions 
supplemented with FBS or CDSF conditions transferred back to standard conditions, the 
Gli2 transcript level was maintained, which was associated with the incidence of 
teratoma formation (Fig. 3.8). Surprisingly, pharmacological inhibition of Gsk3β greatly 
activated Gli2 expression in mouse ESCs cultured under CDSF conditions, and rescued 
their tumor-like growth (Fig. 3.9).  
 
Discussion 
In this report, it is demonstrated that Gli2 encoding an oncogenic transcription factor 
downstream of Hh signaling is expressed in mouse and human ESCs. Mouse ESCs do not 
autonomously activate Gli2 and Hh signaling. Extrinsic signals from culture 
microenvironment are responsible for the activation of the Hh pathway in mouse ESCs. 
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In concert with the data presented in Chapter 2, surprisingly, the transcriptional activity 
of Gli2 showed tight correlation with the tumorigenicity of mouse ESCs. 
The hedgehog pathway governs specification of cell types, proliferation and survival 
of cells, and patterning and growth of embryos and adults (Ingham and McMahon, 2001). 
Three orthologs of Drosophila Hh in vertebrates have unique roles in embryonic 
development in a combinational manner. Dhh is expressed mostly in reproductive tissues, 
such as the testis and the ovary (Bitgood et al., 1996; Wijgerde et al., 2005; Yao et al., 
2002). Dhh-null mice are viable, but mutant males are infertile (Bitgood et al., 1996). Ihh 
is specifically expressed in the primitive endoderm (Dyer et al., 2001), the gut (van den 
Brink, 2007), and the cartilage during bone formation (Vortkamp et al., 1996). Shh 
attracts much more attention because Shh is most broadly expressed. Shh is involved in 
embryongenesis, organogenesis and also stem cell maintenance in adults (Varjosalo and 
Taipale, 2008). 
Approximately 25% of cancer-associated deaths are correlated with the disregulated 
activation of the Hh signal (Lum and Beachy, 2004). Aberrant expression of genes 
involved in the Hh signaling pathway has been implicated in tumorigenic transformation 
of normal cells (Wetmore, 2003). Furthermore, Holoprosencephaly (HPE), a defect of the 
forebrain and midface in humans, is associated with the heterozygous mutation in Shh 
(Roessler et al., 1996). Overexpression of Shh (Oro et al., 1997) or Gli2 (Grachtchouk et 
al., 2000) in the skin of transgenic mice induces development of basal cell carcinoma, the 
most common skin tumors in Caucasians. 
Gli2 is the main modulator of Hh signaling (Bai et al., 2002). In addition, the 
activation of Gli2 requires some other cross regulatory mechanisms. For example, TGFβ 
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is an efficient transcriptional inducer of Gli2 activation in a Smad-dependent manner 
(Dennler et al., 2007). This finding explains why human ESCs cultured under mTeSR 
media, which is a chemically-defined serum-free medium including highly concentrated 
TGFβ, abundantly transcribes GLI2. Furthermore, SHH can crosstalk with extracellularly 
regulated kinase (ERK; Riobo et al., 2006). Moreover, the SHH signal has synergistic 
interactions with FGFs, WNTs and BMPs during development (Bellusci et al., 1997; 
Brewster et al., 2000; Laufer et al., 1994; Meyers and Martin, 1999; Munsterberg et al., 
1995; Murtaugh et al., 1999; Yang and Niswander, 1995). This may explain why 
supplementing Shh alone could not rescue the tumorignicity of mouse ESCs maintained 
under CDSF conditions. 
The expression pattern of Gli2 in undifferentiated and differentiated mouse ESCs is 
similar to ones in prostate cancer cells and epithelial cells (Thiyagarajan et al., 2007).  
Gli2 is aberrantly overexpressed in prostate cancer and tumor cells, whereas the 
expression level of Gli2 is quite low in normal prostate cells. Knockdown of Gli2 
expression by short-hairpin (sh) RNA significantly reduced the growth rate of prostate 
cancer cells both in vitro and in vivo. Furthermore, overexpression of Gli2 in prostate 
epithelial cells resulted in their accelerated growth and the cell cycle progression 
(Thiyagarajan et al., 2007). Disregulated Shh expression often interacts with the insulin-
like growth factor (IGF)/ phosphoinositide 3-kinase (PI3-kinase)/ Akt pathway, which 
induces a synergistic effect on the incidence of tumors (Rao et al., 2004). 
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Figures 
 
Figure 3.1. Global gene expression profiles showed Gli2 transcripts in mouse ESCs. 
(A): Results obtained with Illumina mouse whole genome expression microarray (“Puro 
vs Ctrl”) were compared with a published data set (“Oct(-) Day 0” through “Day 6”;  
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Figure 3.1 (cont.) 
Matoba, et al., 2006). (B): Expression microarray results (Walker et al., 2007) show that 
Gli2 expression is downregulated during differentiation of mouse ESCs LIF-, but 
upregulated by retinoic acid 1µM.  
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Figure 3.2. Confirmation of Gli2 expression pattern in mouse and human ESCs. (A): 
Shh signaling pathway. (B): Undifferentiated (Undif.) mouse ESCs (Oct3/4+) express 
genes downstream of Shh, but do not express Shh. “Dif.”, differentiated. (C): Human 
ESCs (H1; SOX2, NANOG & OCT4A+) express genes downstream of Shh. Ef1α and 
HPRT are loading controls. “RT-” for negative controls. 
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Figure 3.4. CDSF culture condition downreguated Gli2 expression in 
undifferentiated ESCs. Mouse ESCs cultured under chemically-defined serum-free 
conditions (CDSF) downregulated expression of Gli1, Gli2, Ptc and Eras compared to 
those cultured under standard conditions. Ef1α is a loading control.  
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Figure 3.5. CDSF conditions supplemented with Shh  failed to promote the 
proliferation and the tumor-like growth of mouse ESCs. (A and A’): phase contrast 
and fluoresce images of mouse ESC line that expresses enhanced green fluorescent 
protein (EGFP) under the Oct3/4 promoter, which was cultured under CDSF conditions 
supplemented with Shh 500 ng/ml. (B and C): Normalized cumulative cell counts after 
three passages under CDSF conditions  or CDSF conditions with 100 ng/ml or 500 ng/ml 
Shh. (D): mouse ESCs cultured under CDSF conditions with Shh failed to generate 
teratomas up to 10 months. Bar, 1 cm. 
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Figure 3.6. Mouse teratocarcinoma cell lines F9 and P19 express genes downstream 
of Shh. F9 and P19 expressed genes downstream of the Shh pathway examined except 
Gli3 and Shh. Ef1α is a loading control. “RT-” for negative controls.   
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Figure 3.7. F9 and P19 cells cultured under CDSF conditions still maintain Gli2 
expression. F9 and P19 cells cultured in CDSF conditions maintained the expression of 
Gli2 and Eras, but Gli1 and Ptc became undetectable, which indicates that the Shh 
pathway was not activated.  Ef1α is a loading control. 
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Figure 3.8. Gli2 expression is consistent with tumorigenicity of mouse ESCs. Genes 
involved in the Shh signaling pathway became upregulated in CDSF conditions 
supplemented with FBS (CDSF+FBS), and CDSF conditions brought back to standard 
conditions (CDSF to Stand.), when compared with CDSF conditions. Ef1α is a loading 
control. 
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Figure 3.9. Upregulation of Gli2 in mouse ESCs cultured under CDSF conditions 
supplemented with the Gsk3β inhibitor is associated with the incidence of teratoma 
formation. The tumor-like growth of mouse ESCs cultured under CDSF conditions 
supplemented with the Gsk3β inhibitor (CDSF+iGsk3β) is associated with upregulation 
of Gli2. Ef1α is a loading control. 
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Table 3.1: Primer sets for RT-PCR 
Gene Forward  Reverse 
Shh TCTGTGATGAACCAGTGGCC GCCACGGAGTTCTCTGCCTTT 
Ptc AACAAAAATTCAACCAAACCTC TGTCTTCATTCCAGTTGATGTG 
Smo TGCCACCAGAAGAACAAGCCA GCCTCCATTAGGTTAGTGCGG 
Gli1 GTCGGAAGTCCTATTCACGC CAGTCTGCTCTCTTCCCTGC 
Gli2 GTTCCAAGGCCTACTCTCGCCTG CTTGAGCAGTGGAGCACGGACAT 
Gli3 AGCAAGCAGGAGCCTGAAGTCAT GTCTTGAGTAGGCTTTTGTGCAA 
SHH GGAGTCTCTGCACTACGAG GTCGCTGTAGAGCAGCCG 
PTC CTTCGCTCTGGAGCAGATTT CAGGACATTAGCACCTTCT 
SMO ACGAGGACGTGGAGGGCTG CGCACGCTATCGGTAGTTCT 
GLI1 AGTAGCTATGGCGAGCCCT TAGGAGCCTCCTGGAGATGT 
GLI2 ACGATGAGCGGCTGAGATG TCACTCAGACAGTTGCTGCT 
GLI3 CAGCTCCACGACCACTGAA TCCATGGCAAACACCGTCC 
SOX2 ATGCACCGCTACGACGTGA CTTTTGCACCCCTCCCATTT 
NANOG GGCAAACAACCCACTTCTGC TGTTCCAGGCCTGATTGTTC 
OCT4A GACCTGGCTAAGCTTCCAAGG CCTCAAAGCGGCAGATGGTCGTT
TG 
HPRT CGTGGGGTCCTTTTCACCAGCAAG AATTATGGACAGGACTGAACGTC 
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CHAPTER 4 
Conclusion 
 
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) hold great 
promise for regenerative medicine and tissue engineering because they have the 
capability to self-renew and differentiate into all of the tissues or organs in our body. 
However, there are hurdles that hamper application of ESCs and iPSCs for stem cell 
therapies, such as the heterogeneous nature of ESC culture and the tumor-like growth of 
ESCs and iPSCs. To prevent the growth of teratomas in therapeutic transplanted tissue 
replacements, it is necessary to establish methods for efficiently manipulating cell fate 
decisions in PSCs and to understand the mechanism responsible for tumorigenesis in the 
stem cells. To our surprise, the mechanism of teratoma formation from ESCs has 
received little attention to date. Thus, by using mouse ESCs as a model, our research 
group studies the mechanism of the tumor-like growth of ESCs. The goal of this research 
project is to eliminate the tumorigenic property of ESCs, which will make human induced 
pluripotent stem cells amenable to stem cell-based therapies. 
      In Chapter 2, I present experimental evidence to suggest that short-term CDSF culture 
suppresses the tumor-like growth of mouse ESCs, which is reversed by pharmacological 
inhibition of Gsk3β. The standard method to culture mouse ESCs is to provide cells with 
basal medium plus 15% fetal bovine serum (FBS), which contains a variety of unknown 
factors that can promote survival and growth of mouse ESCs. I found that mouse ESCs 
cultured under uniquely formulated chemically defined serum free (CDSF) conditions 
failed to form teratomas, whereas the ones cultured under standard conditions developed 
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into tumors. These data indicate that uncharacterized factors in serum may be responsible 
for the tumor-like growth of mouse ESCs. Although the pluripotency of mouse ESCs 
cultured under CDSF conditions needs to be evaluated by their germline transmission, the 
present data demonstrate that they still can differentiate into three germ layers in vitro 
(Furue et al., 2005) and retain the potential to grow as teratomas. The inhibitor of Gsk3β 
could efficiently promote the proliferation of mouse ESCs and rescue their tumor-like 
growth through upregulation of the oncogenic transcription factor Gli2, but not Eras and 
c-Myc. Therefore, these data suggest that Gsk3β governs the tumor-like growth of mouse 
ESCs by means of a mechanism separate from the one to support the pluripotency of 
ESCs.  
      In Chapter 3, we demonstrated that Gli2, a downstream target of the growth factor 
Sonic hedgehog (Shh), was expressed in undifferentiated mouse ESCs and became 
downregulated during differentiation. Although the Gli2 protein is activated by Shh, the 
Gli2 transcripts were expressed abundantly in mouse ESCs without endogenous Shh 
expression detected. Furthermore, expression of Gli2 in mouse ESCs showed dependency 
on the presence of animal serum in culture. Surprisingly, the Gli2 expression pattern was 
tightly correlated with the tumorigenicity of mouse ESCs, such that when mouse ESCs 
showed Gli2 expression, they efficiently developed into teratomas. However, when Gli2 
expression was downregulated, mouse ESCs still maintained pluripotency. Therefore, 
Gli2 expression is associated with the tumorigenic property of mouse ESCs, which can 
serve as a novel marker, but is dispensable for the self-renewal of mouse ESCs. 
      Multiple pathways may regulate the tumor-like growth of mouse ESCs. These data 
lay the foundation for further investigation to identify other signaling pathways 
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responsible for the tumor-like growth of mouse ESCs, which may be independent from 
the mechanism of self-renewal. Genetic manipulation of mouse ESCs using Gli2 cDNA 
will help determine its role in tumorigenesis in mouse ESCs. These findings have a great 
impact on research of human ESCs and iPSCs and should be tested in these human 
pluripotent stem cells. The first human ESCs-based stem cell therapy for spinal cord 
injury was initiated by Geron Corporation last month (October, 2010). Geron is the only 
company to date which received approval from the U.S. Food and Drug Administration 
(FDA). Currently, the clinical trial is under the phase 1, which is to test the safety of the 
treatment, and to regularly monitor signs of tumor growth. While we are waiting for the 
safety result, the findings presented in this thesis may potentially lead to a solution for 
efficient differentiation of human iPSCs to a desired cell type, while the tumor-like 
property of human iPSCs is inhibited.     
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